Share

EORTC presentations at ENCR Scientific Meeting in Baveno, Italy Oct 5-7 2016

EORTC is conducting epidemiological outcome research, in partnership with population-based cancer registries in Europe, in part to evaluate real-world effectiveness of treatments tested in clinical research. As part of this, two studies will be presented as oral presentations at the European Network of Cancer Registries Scientific Meeting on October 7 under the theme ‘Cancer Registries and Clinical Data’.

The first study “Survival differences in Hodgkin lymphoma patients treated inside and outside clinical trials” will link data from six EORTC lymphoma trials and the Netherlands Cancer Registry (IKNL) to evaluate trial participation rate.

The same data is further linked with the Netherlands Patients Reported Outcome Cancer Registry (PROFILES) in the context of the second study: “Quality of life according to trial participation among Hodgkin lymphoma survivors.” Both studies are conducted in partnership with IKNL.

Back to news list

Related News

  • Professor Benjamin Besse becomes President of EORTC

  • CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer

  • EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials

  • New study confirms a key quality of life tool can be used with adolescents with cancer

  • “Changing practice, improving lives”: EORTC publishes its Annual Report 2025

  • This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research

  • Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer

  • Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma

  • EORTC’s presence at ESTRO 2026

  • Independent, academic cancer trials are vital to improve patient outcomes worldwide